Albert Bourla (Greek: Άλμπερτ Μπουρλά; born October 21, 1961) is a Greek-American veterinarian and businessman known for serving as the chairman and chief executive officer of the pharmaceutical company Pfizer. He joined the company in 1993 and has held several executive roles across Pfizer's divisions.

As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose, “Breakthroughs that change patients’ lives,” with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.

6 days ago · Pfizer CEO Albert Bourla has expressed concerns that ongoing tariff uncertainties are impeding the company's potential investments in U.S. manufacturing and research and development (R&D). During a recent earnings call, Bourla emphasized that the lack of clear trade policies, particularly regarding tariffs, is causing the company to adopt a ...

Apr 24, 2025 · Pfizer CEO Albert Bourla sees ‘a scientific renaissance’ in the U.S. amid backdrop of political threats to the future of research

6 days ago · Nevertheless, Albert Bourla has been lobbying the U.S. government—as high as President Donald Trump himself—to skip the pharmaceutical industry tariffs, which Trump has threatened, in part as a way to shore up U.S. national security. ... Pfizer has accounted for about $150 million in tariff impacts for 2025, CFO Dave Denton noted. That ...

6 days ago · Pfizer's CEO, Albert Bourla, said tariffs are preventing the company from making "tremendous investments" in the US. Leigh Vogel/Getty Images for Concordia Summit 2025-04-30T04:30:53Z

Albert Bourla became CEO of Pfizer in 2019 – the pinnacle of a career at Pfizer spanning more than two decades, multiple continents and several different business functions. When he took the helm of the global pharmaceutical company, he accelerated a transformation to become a more science-driven, innovative company.

Take a look below to see where Pfizer, and our CEO Albert Bourla, landed on a variety of lists—including TIME’s 100 Most Influential Companies and Forbes America’s Dream Employers—recognizing both our work in the lab and in the office.

6 days ago · Like his Big Pharma peers, Pfizer (PFE) CEO Albert Bourla is waiting for the US government to finalize its decision on whether to place a 25% tariff on pharmaceutical imports. To be sure, he said ...